Press release
Cardiac Biomarkers Market Grows with CVD Burden and Rapid Diagnostic Advancements | Abbott Laboratories, Beckman Coulter, Roche Diagnostics Corporation, Becton Dickinson and Co.
Cardiac Biomarkers Market
Cardiac Biomarkers Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With rising cardiovascular disease burden, advances in point-of-care testing, and increasing utilization of troponins, BNP, and CK-MB, the report delivers strategic insights for stakeholders in cardiac diagnostics and emergency care from 2025 to 2033.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/cardiac-biomarkers-market?ophp
Cardiac biomarkers are proteins released into the bloodstream during heart stress or damage, aiding in the diagnosis and monitoring of cardiovascular diseases, especially myocardial infarction (heart attack). Key markers include troponin, CK-MB, and BNP. The market is expanding due to rising cardiovascular disease prevalence, demand for rapid diagnostic tools, and technological innovation in point-of-care testing.
Cardiac Biomarkers Market Competitors Overview:
Abbott Laboratories, Beckman Coulter, Roche Diagnostics Corporation, Becton Dickinson and Co., Bio-Rad Laboratories, BioMerieux, Siemens Healthcare, LumiraDx, Randox laboratories, and Thermo Fisher Scientific.
Important Industry Updates of 2023, 2024 and 2025:
✅ 2024 - FDA cleared Polymedco's PATHFAST hs‐cTnI-II assay for point-of-care cardiac troponin testing delivering ~17-min results-enabling rapid emergency department workflows.
✅ Q1 2025- FDA granted the first 510(k) clearance for an Lp(a) assay in molar units (Roche's Tina-quant®, for ASCVD risk stratification)
Methodology and Scope
The Cardiac Biomarkers Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cardiac-biomarkers-market?ophp
Cardiac Biomarkers Market Segments Overview:
∎ By Cardiac Biomarker Tests (Troponin, Creatine kinase, Myoglobin, Galectin-3, Other Biomarker Tests)
∎ By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Angina, others)
∎ By Testing Location (Laboratory Testing, Point of Care Testing)
The troponin segment dominates due to its critical role in diagnosing myocardial infarction and its widespread use in emergency settings for acute coronary syndrome evaluation.
Regional Overview for Cardiac Biomarkers Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
North America holds the highest share of the cardiac biomarkers market, fueled by high cardiovascular disease prevalence and early diagnostic adoption. Asia Pacific is the fastest growing region, with rising heart disease burden, growing awareness, and improved diagnostic infrastructure.
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/customize/cardiac-biomarkers-market?ophp?ophp
The Report Covers:
➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the Cardiac Biomarkers market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Cardiac Biomarkers market?
Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Biomarkers Market Grows with CVD Burden and Rapid Diagnostic Advancements | Abbott Laboratories, Beckman Coulter, Roche Diagnostics Corporation, Becton Dickinson and Co. here
News-ID: 4134922 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Autonomous Data Platform Market to Reach USD 14.96 Billion by 2032, Report by Da …
Overview of the Autonomous Data Platform Market
The Autonomous Data Platform (ADP) market is witnessing rapid growth, driven by digital transformation and the increasing need for real-time data analytics. ADPs use Artificial Intelligence (AI) and Machine Learning (ML) to automate data management, enabling businesses to make faster, data-driven decisions while minimizing human intervention. These platforms enhance operational efficiency, reduce errors, and allow enterprises to focus on strategic initiatives. ADPs are increasingly…
Global 6G Technology Market to Reach USD 9.03 Billion by 2032, Report by DataM I …
Overview of the Global 6G Technology Market
The 6G technology market represents the next frontier in wireless communication, promising unprecedented advancements in speed, connectivity, and intelligence. Building upon the foundation laid by 5G, 6G aims to deliver peak data rates exceeding 1 terabit per second, ultra-low latency, and seamless integration of artificial intelligence (AI) and quantum-resistant encryption. These capabilities are set to revolutionize industries such as healthcare, automotive, manufacturing, and entertainment…
Spinal Muscular Atrophy Treatment Market to Reach USD 20.06 Billion by 2033, Rep …
Overview of the Spinal Muscular Atrophy Treatment Market
Spinal Muscular Atrophy (SMA) is a rare genetic disorder characterized by progressive muscle weakness, leading to severe physical disability and, in many cases, early death. The advent of innovative therapies has significantly altered the treatment landscape for SMA, offering hope for improved patient outcomes. Gene therapies, such as onasemnogene abeparvovec (Zolgensma), nusinersen (Spinraza), and risdiplam (Evrysdi), have demonstrated efficacy in increasing survival rates…
United States Prime Editing and CRISPR Market 2025 | Growth Drivers, Key Players …
Market Size and Growth
Prime Editing and CRISPR Market is estimated to grow at a CAGR of 24.1% during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ July 2025 - Prime Medicine announced an additional investment of up to $24 million from the Cystic Fibrosis Foundation to advance gene editing therapy targeting the G542X mutation, a prevalent cystic fibrosis-causing mutation with no current therapies.
✅ July 2025 - CRISPR…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
